Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMCO: Avelumab vs Chemotherapy in MSI Metastatic Colorectal Cancer
NCT03186326Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Apr 2018
- Primary completion
- May 2022
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in metastatic colorectal cancer (mCRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Apr 2018; status: completed.
02
Drugs
avelumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03186326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186326.